Skip to main content

Integrated analysis of a NLRP3-dependent adaptive resistance mechanism to pembrolizumab immunotherapy in advanced gastroesophageal cancer

Research Grant
Duke Scholars

Administered By

Medicine, Medical Oncology

Awarded By

Merck Sharp & Dohme

Start Date

January 21, 2022

End Date

January 21, 2026
 

Administered By

Medicine, Medical Oncology

Awarded By

Merck Sharp & Dohme

Start Date

January 21, 2022

End Date

January 21, 2026